EUVIMEDEUVIMED entdecken
Crossref

Drug‐associated glaucoma: A real‐world study based on the Food and Drug Administration adverse event reporting system database

Shi-Nan Wu iD, Xiao-Dong Chen, Dan Yan, Yu-Qian Wang, Shao-Pan Wang iD, Wen-Ying Guan, Caihong Huang, Jiaoyue Hu, Zuguo Liu

Clinical & Experimental Ophthalmology · 2025

DOI: 10.1111/ceo.14454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical & Experimental Ophthalmology, 2025. Verfasst von Shi-Nan Wu und 8 weiteren Autor:innen. Beteiligte Einrichtung: Xiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research…. Hauptthemen laut MEDLINE: Adverse Drug Reaction Reporting Systems, Glaucoma, United States Food and Drug Administration, Drug-Related Side Effects and Adverse Reactions. Die Arbeit wurde bisher 30-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

This study aims to assess the risk of drug‐associated glaucoma and track its epidemiological characteristics using real‐world data.

Methods

Adverse event reports from the Food and Drug Administration Adverse Event Reporting System (FAERS) from January 2004 to December 2023 were analysed. Disproportionality analysis and the Bayesian Confidence Propagation Neural Network algorithm were used. The study classified drugs associated with glaucoma, assessed risk levels, and compared drug‐induced times across different categories.

Results

Eight hundred and five drugs were linked to glaucoma in the FAERS database. Disproportionality analysis identified 46 drugs with significant risk, mainly adrenergic medications (clobetasol propionate, fluocinolone acetonide), antihypertensives (hydrochlorothiazide), insulin (insulin human), anticholinergics (umeclidinium, darifenacin), VEGF inhibitors (brolucizumab, faricimab), and psychotropics (topiramate, ziprasidone). The top three high‐risk drugs were clobetasol propionate, umeclidinium, and fluocinolone acetonide. The shortest drug‐induced times were observed with indacaterol, salmeterol, and umeclidinium. Anticholinergic medications had the shortest drug‐induced time among all categories. Females (62.5%) and the elderly (average age 63.5 ± 16.8 years) were predominantly affected. Reports of drug‐associated glaucoma increased over the years.

Conclusion

Preventing drug‐associated glaucoma is more effective than treatment. Identifying the risk and drug‐induced times of systemic and ophthalmic drugs can reduce occurrence risk. Clinical practitioners should be vigilant and inform patients of these risks.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adverse Drug Reaction Reporting SystemsGlaucomaUnited States Food and Drug AdministrationDrug-Related Side Effects and Adverse ReactionsHumansUnited StatesDatabases, FactualFemaleMaleMiddle AgedAgedAdultAged, 80 and overAntihypertensive AgentsYoung AdultIntraocular PressureRetrospective Studies

Stichwörter der Autor:innen

FAERSdisproportionality analysesdrug induction timedrug‐induced riskglaucoma

Substanzen

Antihypertensive Agents

Autor:innen und Institutionen

  • Xiamen University affiliated Xiamen Eye Center, Fujian Provincial Key Laboratory of Ophthalmology and Visual Science, Fujian Engineering and Research Center of Eye Regenerative Medicine, Eye Institute of Xiamen Universi…
  • Institute of Artificial Intelligence, Xiamen University, Xiamen, China.
  • Department of Ophthalmology, Xiang'an Hospital of Xiamen University, Xiamen, China.
  • Department of Ophthalmology, The First Affiliated Hospital of University of South China, Hengyang, China.

ORCID-Profile: Shi-Nan Wu, Shao-Pan Wang

Zitieren

APA

Wu, S. N., Chen, X. D., Yan, D., Wang, Y. Q., Wang, S. P., Guan, W. Y., Huang, C., Hu, J., & Liu, Z. (2025). Drug‐associated glaucoma: A real‐world study based on the Food and Drug Administration adverse event reporting system database. Clinical & Experimental Ophthalmology. https://doi.org/10.1111/ceo.14454

Vancouver

Wu SN, Chen XD, Yan D, Wang YQ, Wang SP, Guan WY, et al. Drug‐associated glaucoma: A real‐world study based on the Food and Drug Administration adverse event reporting system database. Clinical & Experimental Ophthalmology. 2025. doi:10.1111/ceo.14454

BibTeX
@article{Wu2025,
  author = {Wu, Shi-Nan and Chen, Xiao-Dong and Yan, Dan and Wang, Yu-Qian and Wang, Shao-Pan and Guan, Wen-Ying and Huang, Caihong and Hu, Jiaoyue and Liu, Zuguo},
  title = {Drug‐associated glaucoma: A real‐world study based on the Food and Drug Administration adverse event reporting system database},
  journal = {Clinical & Experimental Ophthalmology},
  year = {2025},
  doi = {10.1111/ceo.14454}
}
Kostenlos starten →